CVS Health raises 2025 guidance and forecasts stronger 2026 profits

CVS Health raised its full-year 2025 revenue forecast to at least $400 billion and raised its adjusted EPS outlook to $6.60–$6.70 per share. For 2026, it expects earnings of $7.00–$7.20 per share, reflecting confidence in improved performance from its insurance and pharmacy businesses. Shares rose over 2% after the announcement, as investors welcomed the updated guidance and business-model strength.